Displaying drugs 76 - 100 of 136 in total
| DrugBank ID | Name CAS Number |
Weight Formula |
Structure | Categories | Therapeutic Indication |
|---|---|---|---|---|---|
| DB00065 |
Infliximab
170277-31-3 |
144190.3000 C6428H9912N1694O1987S46 |
|
Immunomodulatory Agents / Immunosuppressive Agents | To manage the signs and symptoms, as well as to induce and maintain clinical remission in adults with moderate to severe active Crohn's disease or ... |
| DB00064 |
Serum albumin iodonated
9048-49-1 |
66472.2000 C2936H4624N786O889S41 |
|
Imaging Agents | For determination of total blood and plasma volumes |
| DB00063 |
Eptifibatide
188627-80-7 |
831.9620 C35H49N11O9S2 |
|
Anticoagulants / Antiplatelet Agents / Platelet Aggregation Inhibitors | For treatment of myocardial infarction and acute coronary syndrome. |
| DB00062 |
Human Serum Albumin
9048-49-1 |
66472.2000 C2936H4624N786O889S41 |
|
Serum substitutes | For treatment of severe blood loss, hypervolemia, hypoproteinemia |
| DB00061 |
Pegademase bovine
9026-93-1 |
40788.2000 C1821H2834N484O552S14 |
|
Enzyme Replacement Agents | For treatment of adenosine deaminase deficiency |
| DB00060 |
Interferon beta-1a
145258-61-3 |
20027.0000 C908H1408N246O252S7 |
|
Immunomodulatory Agents / Antiviral Agents | For treatment of relapsing/remitting multiple sclerosis, also for condyloma acuminatum |
| DB00059 |
Pegaspargase
130167-69-0 |
31731.9000 C1377H2208N382O442S17 |
|
Antineoplastic Agents | For treatment of acute lymphoblastic leukemia |
| DB00058 |
Alpha-1-proteinase inhibitor
9041-92-3 |
44324.5000 C2001H3130N514O601S10 |
|
Enzyme Replacement Agents | For treatment of panacinar emphysema |
| DB00057 |
Satumomab Pendetide
138955-26-7 |
141478.9000 C6268H9708N1666O1971S48 |
|
Imaging Agents | For diagnosis of extrahepatic malignant cancers |
| DB00056 |
Gemtuzumab ozogamicin
220578-59-6 |
|
Antineoplastic Agents | For treatment of CD33-positive acute myeloid leukemia in patients 60 and over who are not candidates for other chemotherapy. | |
| DB00055 |
Drotrecogin alfa
60202-16-6 |
55000.0000 C1786H2779N509O519S29 |
|
Antisepsis Agents | For reduction of mortality in patients with severe sepsis. |
| DB00054 |
Abciximab
143653-53-6 |
145651.1000 C6462H9964N1690O2049S48 |
|
Anticoagulants / Antiplatelet Agents | Abciximab is indicated as an adjunct to percutaneous coronary intervention for the prevention of cardiac ischemic complications in patients undergo... |
| DB00053 |
Imiglucerase
143003-46-7 |
55597.4000 C2532H3854N672O711S16 |
|
Enzyme Replacement Agents | For the treatment of Gaucher's disease (deficiency in glucocerebrosidase) |
| DB00052 |
Somatropin recombinant
12629-01-5 |
22129.0000 C990H1532N262O300S7 |
|
Anabolic Agents / Hormone Replacement Agents | For treatment of dwarfism, acromegaly and prevention of HIV-induced weight loss |
| DB00051 |
Adalimumab
331731-18-1 |
144190.3000 C6428H9912N1694O1987S46 |
|
Antirheumatic Agents / Immunomodulatory Agents | For treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and Crohn's disease. |
| DB00049 |
Rasburicase
134774-45-1 |
34109.5000 C1521H2381N417O461S7 |
|
Antihyperuricemic Agents | For treatment of hyperuricemia, reduces elevated plasma uric acid levels (from chemotherapy) |
| DB00048 |
Collagenase
9001-12-1 |
112023.2000 C5028H7666N1300O1564S21 |
|
Anti-Ulcer Agents / Topical | Used to promote debridement of necrotic tissue in the treatment of severe burns and dermal ulcers including decubitus ulcers. |
| DB00047 |
Insulin Glargine
160337-95-1 |
6063.0000 C267H408N72O77S6 |
|
Hypoglycemic Agents / Antidiabetic | For the treatment of Type 1 or 2 diabetes mellitus in patients over 17 years old who require a long-acting (basal) insulin for the control of hyper... |
| DB00046 |
Insulin Lispro
133107-64-9 |
5808.0000 C257H387N65O76S6 |
|
Hypoglycemic Agents / Antidiabetic | For the treatment of Type 1 or 2 diabetes mellitus. To be used in conjunction with an intermediate or long-acting insulin except when used in a con... |
| DB00045 | OspA lipoprotein |
27743.1000 C1198H2012N322O422S2 |
|
Vaccines | For prophylactic treatment of Lyme Disease |
| DB00044 |
Lutropin alfa
152923-57-4 |
23390.3000 C1014H1609N287O294S27 |
|
Fertility Agents | For treatment of female infertility |
| DB00043 |
Omalizumab
242138-07-4 |
145058.2000 C6450H9916N1714O2023S38 |
|
Immunomodulatory Agents / Anti-Asthmatic Agents | For treatment of asthma caused by allergies |
| DB00042 |
Botulinum Toxin Type B
93384-44-2 |
150804.0000 |
|
Antidystonic Agents | For the treatment of patients with cervical dystonia to reduce the severity of abnormal head position and neck pain associated with cervical dystonia. |
| DB00041 |
Aldesleukin
85898-30-2 |
15314.8000 C690H1115N177O202S6 |
|
Antineoplastic Agents | For treatment of adults with metastatic renal cell carcinoma. |
| DB00040 |
Glucagon recombinant
9007-92-5 |
3767.1000 C165H249N49O51S1 |
|
Antihypoglycemic Agents | For treatment of severe hypoglycemia, also used in gastrointestinal imaging |
Displaying drugs 76 - 100 of 136 in total